Literature DB >> 16434634

Biomedical patents and the public's health: is there a role for eminent domain?

Aaron S Kesselheim1, Jerry Avorn.   

Abstract

Keywords:  Health Care and Public Health; Legal Approach

Mesh:

Year:  2006        PMID: 16434634     DOI: 10.1001/jama.295.4.434

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative Study.

Authors:  Carolyn L Treasure; Jerry Avorn; Aaron S Kesselheim
Journal:  Milbank Q       Date:  2015-12       Impact factor: 4.911

2.  Economic return of clinical trials performed under the pediatric exclusivity program.

Authors:  Jennifer S Li; Eric L Eisenstein; Henry G Grabowski; Elizabeth D Reid; Barry Mangum; Kevin A Schulman; John V Goldsmith; M Dianne Murphy; Robert M Califf; Daniel K Benjamin
Journal:  JAMA       Date:  2007-02-07       Impact factor: 56.272

3.  The diminished pipeline for medications to treat mental health and substance use disorders.

Authors:  Peggy L O'Brien; Cindy Parks Thomas; Dominic Hodgkin; Katharine R Levit; Tami L Mark
Journal:  Psychiatr Serv       Date:  2014-11-17       Impact factor: 3.084

Review 4.  Intellectual property policy in the pharmaceutical sciences: the effect of inappropriate patents and market exclusivity extensions on the health care system.

Authors:  Aaron S Kesselheim
Journal:  AAPS J       Date:  2007-08-03       Impact factor: 4.009

5.  Patent challenges and factors associated with successful patent challengers under the patent linkage system: recent evidence from South Korea after the Korea United States free trade agreement.

Authors:  Kyung-Bok Son; Nahye Choi; Boram Lee; Joonsoo Byun; Dong-Wook Yang; Tae-Jin Lee
Journal:  Global Health       Date:  2021-09-28       Impact factor: 4.185

6.  The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?

Authors:  Daniel M Hartung; Dennis N Bourdette; Sharia M Ahmed; Ruth H Whitham
Journal:  Neurology       Date:  2015-04-24       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.